NASDAQ:EWTX | Free Cash Flow | Edgewise Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$42.54M$260,000.00-$42.8M
2025-12-31-$38.59M$73,000.00-$38.67M
2025-03-31-$37.87M$44,000.00-$37.91M
2024-12-31-$26.96M$274,000.00-$27.23M
2024-03-31-$28.6M$297,000.00-$28.9M
2023-12-31-$26.83M$161,000.00-$26.99M
2023-03-31-$22.83M$4.37M-$27.19M
2022-12-31-$11.86M$3.29M-$15.15M
2022-03-31-$12.57M$369,000.00-$12.94M
2021-12-31-$9.42M$79,000.00-$9.5M
2021-03-31-$6.06M$62,000.00-$6.12M
2020-12-31-$4.64M$0.00-$4.64M
2020-03-31-$2.74M$9,000.00-$2.75M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$143.82M$256,000.00-$144.07M
2024-12-31-$109.03M$1.31M-$110.34M
2023-12-31-$91.95M$5.75M-$97.69M
2022-12-31-$52.64M$5.55M-$58.18M
2021-12-31-$33.51M$668,000.00-$34.18M
2020-12-31-$14.63M$203,000.00-$14.84M